Objectives: Human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) can generate any given cell type in the human body. One challenge for cell-replacement therapy is the efficient differentiation and expansion of large quantities of progenitor cells from pluripotent stem cells produced under good manufacturing practice (GMP). FOXA2 and SOX17 double positive definitive endoderm (DE) progenitor cells can give rise to all endoderm-derived cell types in the thymus, thyroid, lung, pancreas, liver, and gastrointestinal tract. FOXA2 is a pioneer transcription factor in DE differentiation that is also expressed and functionally required during pancreas development and islet cell homeostasis.
INTRODUCTION
The self-renewal capacity and the wide differentiation potential of pluripotent ESC lines have great therapeutic potential to treat chronic diseases such as diabetes mellitus, blindness, or neurodegeneration. Islet transplantation can cure brittle type 1 diabetic patients; however, donor islets are rare and preclude therapy for many patients. ESCs can represent an attractive source to produce functional b-cells from stem cells in the culture dish. Current problems include the expansion of large quantities of progenitor cells using GMP facilities and the generation of functional mature b-cells for transplantation [1] . The existing differentiation protocols are directly translated from developmental studies in vivo [2, 3] and act by mimicking the developmental programs in vitro to facilitate generation and upscaling of pancreatic b-cells [4, 5] . A major drawback of these protocols is the use of recombinant proteins and ligands that show variable activity and stability and are often exposed to animal products that might be contaminated with yet unidentified pathogens [4, 5] . One strategy to overcome this problem and implement cheap and efficient GMP-grade ESC differentiation protocols is to replace biologics by small molecule compounds with stable and reproducible activity. During embryogenesis, different developmental pathways regulate definitive endoderm (DE) formation and patterning, including the Wnt, fibroblast growth factor (FGF), transforming growth factor b (TGF-b)/ Nodal/ActivinA (AA), bone morphogenic protein (BMP), and AKT/PI3K [6e9] . Modulating the signaling transduction events and genes involved in these pathways can help recapitulate the developmental processes in vitro. In current protocols, efficient DE induction is achieved by direct exposure of ESCs and iPSCs to recombinant proteins, including Wnt3a and AA [8] . However, these proteins can exhibit highly variable activity in culture, due to incomplete post-translational modifications, lack of stability of biological activity as well as batch-to-batch variations. As it is well known that Wnt and Nodal/TGF-b signaling gradients induce and pattern the mesoderm and endoderm germ layer [10] , this can result in variable efficiencies of DE patterning in vitro from one week to another. Induction of heterogeneous DE populations can lead to a great inconsistency in establishing long-term differentiation protocols over 20e40 days towards one particular cell fate [4, 5] . Small molecules can serve as tools to replace current proteins and induce the differentiation of ESCs. These molecules can effectively act on target proteins thereby modulating different signaling pathways [11] . The major advantage of using small molecules is that they can be synthesized in high amounts and with higher purity and stored in a way that the substances have reproducible activity. High-throughput screens to monitor directed endodermal differentiation have been reported previously [11, 12] . These screens introduce small molecules that modulate the TGF-b pathway, replacing the use of AA in differentiation cocktails to induce endoderm; however, there is still a great need to identify novel potent endoderm inducers that can effectively augment terminal pancreatic differentiation protocols [4, 5, 11, 13, 14] . Towards this aim, we set-up a high-content screen in mESCs and tested 23,406 small molecules. We identified the Rho associated coiled like protein kinase (ROCK) inhibitor Fasudil as a small molecule that efficiently induces DE in both mESCs and hESCs. Moreover, when compared with the traditional Wnt3a and AA endoderm induction cocktail, ROCKi treated cells showed similar differentiation towards DE. We show that another analogue of Fasudil, RKI-1441, showed similar differentiation efficiencies of mESCs and hESCs towards DE indicating that ROCKi is sufficient to induce DE in culture. Furthermore, the ROCKi differentiates the PSCs towards anterior definitive endoderm (ADE), which gives rise to thymus, thyroid, lung, liver, and pancreas. We found that ROCKi does not induce extraembryonic visceral endoderm or mesoderm in the cell culture system. Additionally, ROCKi-induced DE from hESCs differentiated efficiently into pancreatic progenitors (PP), suggesting a supportive role of ROCKi in pancreatic differentiation. Altogether, we introduce a family of small molecule ROCKis and a novel mechanism that can robustly induce DE/ADE differentiation of PSCs in culture thereby replacing biologics in the differentiation medium.
METHODS AND MATERIALS
2.1. Culture, maintenance, and differentiation of mouse and human embryonic stem cells In-house made (IDG) mESCs (FoxA2-Venus/Oct3/4-RFP) were thawed on mitomycin treated feeders and maintained undifferentiated in ES medium based on DMEM (41966-052; Gibco) containing 15% FCS (PAA, A15-108), mLIF (self-made), 12 ml HEPES (2503024, Gibco), 5 ml Penicillin/Streptomycin (15140122; Gibco), and 1 ml 2-mercaptoethanol (Gibco, 31350-010). In vitro differentiation of the mESCs towards endoderm was carried out in monolayer on 0.1% gelatine coated dishes. The cells were mouse embryo fibroblast feeder cells (MEF) depleted and cultured for few consecutive passages on gelatine and ES medium. On the day of differentiation, mESCs were seeded on gelatine coated dishes directly in serum free medium (SFM). SFM was based on advanced DMEM/F-12 (12634028, Gibco) and advanced RPMI (12633020, Gibco) in ratio 1:1.500 ml of SFM was supplemented with 10 ml GlutaMaxÔ (35050061, Gibco), 12 ml HEPES (2503024, Gibco), 5 ml Penicillin/Streptomycin (15140122, Gibco), Cytidine 20 ng/ml final concentration (C122106, Sigma Aldrich). For control endoderm differentiation, SFM was supplemented with 1 ng/ml of murine Wnt3a (1324 WN-CF, R and D systems) and 12.5 ng/ml of Activin A (338-AC, R and D systems). Freshly prepared SFM supplemented with Wnt3a and Activin A was added every day until day 4 to achieve optimum differentiation of mESCs towards definitive endoderm. Compound induced differentiation was achieved by adding 3 mM of Fasudil or other ROCK inhibitors to the SFM instead of Wnt3a and Activin A. The differentiation efficiency was assessed based on endogenous expression of FoxA2 and Sox17. For human ESCs (H9), the cells were thawed on 1:30 geltrex coated dishes along with 10 mM of Y compound for 1 day. The cells were maintained in iPS-Brew medium (130-104-368; Miltenyi Biotech). For differentiation, single cells were seeded on geltrex coated 6-well plates (2 million cells/well). On day 1, the cells were treated with 20 ng/ml WNT3A and 100 ng/ml AA or 10 mM of the ROCK inhibitors for 4 days for DE induction. Figures 3 and 4) . For complete medium change, the medium of the assay plate was discharged and fresh medium from the pre-dilution plate was transferred to the assay plate using Perkin Elmer Janus Mini AJ SM001/384 Tip MDT with sterile Tips (slowest dispensing speed, without touching the cells). After medium change assay, plates were immediately placed into an incubator (37 C and 5% CO2) until day 5 after seeding.
Assay plate processing and immunostaining
On day 5 post seeding, assay plates were washed 1Â with PBS and fixed for 5 min at RT with 4% PFA, rinsed 1Â in PBS and 2Â in PBST (PBS þ 0.1% Tween20) and permeabilized for 10 min in PBS containing 0.1 M Glycin/0.1% Triton X-100. After permeabilization, cells were rehydrated for 10 min in PBST containing 0.1 M Glycin without Triton X-100 and blocked for 30 min with PBSTþ 10% FCS, 0.1% BSA, 3% donkey serum. Primary antibodies were diluted in blocking solution (anti-FoxA2 goat polyclonal AB (Santa Cruz, sc6554) and anti-Oct-3/4 mouse monoclonal AB (Santa Cruz, sc5279), (both 1:800 diluted).
Plates were incubated with 20 ml of the antibody dilution for 1 h at 37 C, rinsed with 1Â with PBST and washed 2Â for 7 min in PBST. Secondary antibodies (Alexa555 anti-mouse IgG and Alexa488 donkey anti-goat, Invitrogen) were diluted in blocking solution (1:800). Secondary antibody solution was added to each well and incubated for 1 h. Secondary antibody dilution was discarded, replaced by PBSTþ containing DAPI, and incubated for 15 min. Plates were rinsed once with PBST and washed twice for 10 min in PBS. All washing steps were done with 80 ml/well. Washing solution was added manually or using Perkin Elmer Janus (384 well Head, slowest dispensing speed).
High content image acquisition
Stained plates were imaged on the Opera confocal imaging system (PerkinElmer) using 10Â objective (UPlanSApo_NA ¼ 0.4). A set of 12 image fields were collected from each well covering the complete well.
Filter and Camera selection were optimized by using the Opera-FilterSelection-Visualization Tool (PerkinElmer). For each measurement, laser power and exposure times were adjusted to the linear detection range. Acquired images were captured and analyzed using Columbus 2.0 software (PerkinElmer) (Supplementary Figure 1) .
Image analysis method developed on Columbus (PerkinElmer, Platform)
As pluripotent cells grow in colonies and differentiated cells grow in monolayer, an image analysis strategy was developed and realized using predefined building blocks and machine learning algorithms from Columbus image analysis options (PerkinElmer). The strategy involved the identification of different cell populations and colonies using the "Find texture regions," which allows the separation of different textures using an interactive training mode (PhenoLOGICÔ). Training sets were performed on representative images in which some examples of a texture class had been selected. Aggregated cells region consisted of one class and single cells region of another. The method 'Find a class' was chosen based on the DAPI staining channel. After the training phase, each image was automatically divided into two regions each being like the particular examples of the training sets. The two resulting output populations, namely "colony-like region and "isolated" cells, were further analyzed to obtain the related morphology and intensity properties. In subsequent building blocks, the populations of interest were selected in order to calculate the intensity and morphology properties. Both enabled the introduction of filtering steps to refine the analysis and identify accurately each object of the populations of interest. The most relevant phenotypic descriptors were then selected on the basis of subsequent quantification (Supplementary Figure 2 Differentiation of H9 cells towards pancreatic progenitors was carried out using an already published protocol [5] . H9 cells were seeded on geltrex coated 6 wells plates with a seeding density of 2 Â 10 6 /well. The cells were treated with Fasudil and RKI-1447 for 4 days to induce DE/ADE differentiation. 20 ng/ml WNT3A, and 100 ng/ml AA was used as a differentiation control. The basal medium used contained RPMI supplemented with 0.5% BSA, 1Â Glutamax. After 4 days, the medium was changed to RPMI supplemented with 0.5% BSA, 10 nM Glucose, 1Â Glutamax, 50 ng/ml FGF7, and 0.25 mM ascorbic acid for 2 days to induce primitive gut tube. For the next 2 days, to induce posterior foregut, the cells were treated with RPMI supplemented with 1Â Glutamax, 10 mM final glucose concentration, 2% BSA, 0.25 mM ascorbic acid, 50 ng/ml FGF7, 0.25 mM SANT-1, 1 mM retinoic acid, Original Article 2.10. Statistical analysis If not otherwise stated, for comparisons of two groups, levels of significance were calculated using the unpaired Student's t test. *, P < 0.01; ***, P < 0.01; ***, P < 0.0001 were used as levels of significance.
RESULTS
3.1. High content screening identifies novel compounds that induce definitive endoderm To facilitate high content screening (HCS) of novel compounds that induce DE, we analyzed exit of pluripotency and induction of endoderm in mESC using immunofluorescence staining against Oct3/4 and FoxA2, respectively. Previous data indicate that FoxA2 is highly expressed in mesendoderm and DE at gastrulation-stage [15] . The in vitro endoderm differentiation protocol used in the screen was based on previously published protocols [8] [6, 12] . To directly test the effect of the small molecules on DE induction and exclude the influence of non-defined material, we used serum-free medium for the screen. Chemically defined medium supported normal growth of mESCs, cultured as a monolayer in 384-well plates (data not shown). The TGFb pathway ligand Activin A and the Wnt pathway inducer Wnt3a efficiently induce mesendoderm and DE around day 4 in in vitro differentiated mESCs as monitored by FoxA2 and Oct3/4 antibody stainings ( Figure 1A,B) . FoxA2 þ cells also showed induction of the DE transcription factor Sox17, indicating efficient DE induction in the HCS assay format using Wnt3a and AA (data not shown).
The initial screen was performed with 23,406 small molecules selected on the basis of chemical diversity and excluding structural features associated with well described interference effects [16] . From the primary screening results covering 23,406 compounds, 400 putative hits were selected for re-test in Hit confirmation study in triplicates (single dose) to confirm their capacity to induce FoxA2 expression in mESCs ( Figure 1C ). The compounds which gave at least Table) . One of the most striking effects on DE differentiation was observed with Fasudil, the only compound with a known molecular target based on the searches performed using public databases such as ChEMBL and PubChem. All other compounds currently have no described direct molecular targets. Fasudil (HA-1077) is a potent ROCK inhibitor [17] . The effect of ROCK inhibitors on DE differentiation of ESCs was not previously described and we selected it for follow-up experiments.
3.2. Fasudil induces definitive endoderm in mouse embryonic stem cells Fasudil increases the survival of single cells during passaging of human ESCs (hESCs) by blocking apoptosis and thereby increasing plating efficiency [18] . The effects of ROCK inhibition on ESC differentiation are not well studied; thus, we analyzed the effect of long-term exposure of Fasudil and its analogues (1,4-diazepine derivatives) on mESCs. Remarkably, Fasudil showed a similar degree of DE induction when compared to the combination of Wnt3a and AA. mESCs responded in a dose-dependent manner to Fasudil treatment with an EC50 of 2.328 mM (Figure 2A,B) . Wnt3a/AA and DMSO were used as positive and negative controls, respectively. Treatment of mESCs with Fasudil resulted in approx. 27% of FoxA2 þ cells, which was comparable to the induction of FoxA2-induced DE by Wnt3a/AA (23%) on day 4 of mESC differentiation ( Figure 2C ). For the HCS, we used FoxA2 as marker for DE differentiation. However, apart from DE, FoxA2 is also expressed in the mesendoderm. To confirm induction of DE, we combined FoxA2 and Sox17 staining [19] . Moreover, Sox17 is expressed in later stages of endoderm-derived organ development [20, 21] . Fasudil induced endoderm cells were double positive for FoxA2 and Sox17 ( Figure 2D ). Treatment with Fasudil and Wnt3a/AA reduced the expression levels of pluripotency markers Oct3/4, Sox2, Nanog, and Klf4 significantly, suggesting efficient endoderm differentiation and exit from pluripotency ( Figure 2E ).
ROCK inhibition leads to the formation of anterior definitive endoderm (ADE)
Previously, it has been shown that mesendoderm and endoderm are induced by high levels of Wnt3a and AA [22] . Furthermore, Wnt3a and Nodal/TGF-b signaling are known to pattern the endoderm in a dosedependent fashion [10] . To test the effect of ROCKi on endoderm induction and patterning, we assessed mESCs using the FoxA2-Venus fusion (FVF) reporter mESC line [15] . During endoderm development and differentiation, expression of FVF marks the mesendoderm (FVF low ) and DE (FVF high ) in a dose-dependent fashion. We treated the FVF mESC line using selected ROCK inhibitors to induce endoderm lineage ( Figure 3A) . A common Wnt3a/AA DE induction paradigm (1 ng/ml Wnt3a þ 12.5 ng/ml AA) was used for comparison to benchmark DE induction efficiency. It is well known that lower levels of AA induce mesoderm and higher levels of AA induce DE [6] . We also used another ROCKi, RKI-1447, to assure that ROCK inhibition is the mechanistic principal that underlies mesendoderm and DE induction. Both Fasudil and RKI-1447 induced expression of FoxA2 and Sox17 (Figure 3B,F,G) . However, the expression of FoxA2 and Sox17 was relatively higher in RKI-1447 treated cells ( Figure 3F,G) . To assess the induction of mesoderm or mesendoderm cells, we looked for the induction of mesoderm marker Brachyury (T). (Figure 3DeF ). Most cells that expressed FoxA2 also expressed significantly higher levels of other endoderm marker genes, such as Sox17 and Cxcr4 ( Figure 3H ). qPCR quantification of ADE genes, such as Hhex and Cer1, showed similar expression in the chemically induced cells than in Wnt3a/AA treated cells, indicating the efficient generation of ADE by the treatment of mESCs with ROCKi ( Figure 3H ). 
Inhibition of ROCK pathway can prime mESCs towards DE
The small GTPases Rho, Rac, and Cdc42 are important regulators of cell polarity, adhesion, and migration via cytoskeletal remodeling, which can also influence gene transcription and differentiation [24] . ROCK is a direct downstream target of the small GTPase RhoA that controls stress fibre formation and cellular contractility. Along with its downstream effectors LIM kinase and Cofilin/ADF, ROCK inhibits actin depolymerization leading to actin filament stabilization and stress fiber formation [25] . ROCK also stimulates myosin II activity, directly by phosphorylation of myosin light chain (MLC) and indirectly by inactivation of MLC phosphatase target subunit I (MYPT1), which dephosphorylates and thus negatively regulates MLC ( Figure 4A ) [26] . Figure 4F ). To test if downstream mediators of ROCK also induced DE we tested the effect of blebbistatin, a direct inhibitor of myosin II activity on mESCs. Interestingly, blebbistatin could also induce DE differentiation in a similar way compared to the Wnt3a/AA positive control (Figure 4FeH) . The most prominent effect on endoderm differentiation was observed with the two potent ROCK inhibitors Thiazovivin and RKI-1447, which inhibit ROCK activity at 0.5 nM and 14.5 mM, respectively.
Treatment with these small compounds significantly increased the amount of FoxA2 þ cells in comparison to the Wnt3a/AA ( Figure 4F ).
However, FoxA2 protein levels in cell lysate of differentiated cells were similar between all compounds and Wnt3a/AA ( Figure 4G ). Interestingly, we observed a slight induction in Sox17 levels in the differentiated cells using the compounds compared to Wnt3a/AA, suggesting better induction of DE after the treatment of mESCs with these compounds ( Figure 4G ). As blebbistatin, a modulator of actin cytoskeleton could induce DE equally; we speculated that the ROCKi used in this experiments can induce DE by modulation of the actin cytoskeleton triggered by ROCK or myosin II inhibition. Figure 5C ). Finally, mRNA quantification of hESCs treated with Fasudil and RKI-1447 revealed significantly higher induction of FOXA2 and SOX17 compared to WNT3A/AA controls (Figure 5DeE ), indicating that prolonged exposure to ROCKi can effectively induce DE in human pluripotent stem cells.
ROCK inhibition promotes the differentiation of hESCs towards pancreatic progenitor stage
The main goal of the screen was to identify small molecules that can not only induce DE but can also efficiently give rise to pancreatic progenitors. To assess the quality of the DE induced by ROCKi, we decided to test its differentiation potential towards pancreatic progenitors. After initial differentiation towards the DE using ROCK inhibitors Fasudil and RKI-1447, the protocol was switched to the recently published pancreatic progenitor differentiation protocol [5] .
After 8 days of differentiation, the cells treated with 10 mM Fasudil and RKI-1447 induce comparable levels of the pancreatic progenitor marker PDX1 when paralleled to control WNT3A/AA treatment in qPCR analysis ( Figure 6B ). This was confirmed by FACS analysis, which revealed that the PDX1 levels were slightly lower in Fasudil (80%) and RKI-1447 (85%), when compared to WNT3A/AA treatment (Figure 6Ee  H) . Notably, both ROCKi-treated cultures showed a PDX1 low population, suggesting that pancreatic differentiation was efficiently induced but slightly delayed ( Figure 6I ). We also analyzed the expression of FOXA2 that is expressed throughout endoderm induction and endodermderived organ formation in ROCKi-treated cells [15] . The expression of FOXA2 was significantly elevated in Fasudil and RKI-1447 treated cells compared to WNT3A/AA treated cells ( Figure 6C ). Interestingly, we observed significantly lower expression of the liver markers AFP and TTR in Fasudil and RKI-1447 treated cells in comparison to WNT3A/AA treated cells ( Figure 6D ). Taken together, these results suggest that ROCKi can direct the differentiation of DE towards pancreatic progenitors. 
DISCUSSION
The efficient differentiation of ESCs into definitive endoderm is a crucial step in generating organ progenitors for the thymus, thyroid, lung, liver, pancreas, and gastrointestinal tract. Directed differentiation and expansion of these DE progenitors to generate terminally differentiated organ cell types is essential to treat diseases such as chronic liver disease or diabetes mellitus. Most current protocols use recombinant proteins such as WNT3A and AA to induce DE cells from hPSCs. However, to introduce xeno-free conditions in human differentiation culture, recent publications have introduced a plethora of small molecules targeting WNT3A and TGF-b pathways [4, 5, 14] . In mouse, the gradients of Tgf-b/Wnt3a and Bmp4 are known to regulate DE formation and patterning [27] . A recently published protocol on generation of pancreatic b cells from hESCs used GDF8; an ALK inhibitor instead of AA and MCX-928; a GSK3b inhibitor instead of recombinant WNT3A [5] . Although these compounds activate the same signaling pathways, the different concentrations and durations used in published protocols may result in variable endoderm patterning and induction of organ progenitors generated in vitro. Thus, we introduce a novel family of ROCK inhibitors that can effectively induce DE in mESCs and hESCs by modulating the cytoskeleton of the PSCs. One advantage of using ROCKi over recombinant proteins can be stable induction of FOXA2-and SOX17-mediated endoderm patterning. The increased use of stable and defined small molecules in the process of PSC differentiation can help in simplifying and devising robust differentiation protocols. We report two potent ROCK inhibitors, Fasudil and RKI-1447 that can direct mESCs differentiation in vitro towards ADE. Both the compounds were also equally effective in directing the differentiation of hESCs into DE. In mESCs, at a concentration of 3 mM Fasudil and RKI-1447 induced DE in absence of LIF. In hESCs, slightly higher concentrations (10 mM) of these compounds were found to induce differentiation. Another ROCK inhibitor, Y-27632, at 10 mM is used to prevent dissociation induced apoptosis during plating of hESCs in particular [28] . It is reported that treatment of hESCs with Y-27632 inhibits ROCK1/2, thereby suppressing an epithelial-to-mesenchymal transition through inhibition of key ligands of TGFb1, GDF6, and WNT signaling [29] . Therefore, we treated hESCs with prolonged exposure of 10 mM of ROCKis Fasudil and RKI-1447. The extended treatment using 10 mM ROCK inhibitors for a period of 4 days leads to formation of DE in hESCs. The efficiency of differentiation in both mESCs and hESC systems was equally comparable to the classical Wnt3A/AA induction. This differentiation towards DE/ADE can be attributed to ROCK inhibition. It has been already reported that ROCKi's are known to alter the actin cytoskeleton of the cells. This affects remodeling of the actin cytoskeleton, thereby provoking differentiation in these cells [26] . The changes induce the differentiation process in the pluripotent cells by activating the PI3Kinase/AKT activity [30] . Also, it has been reported that ROCK inhibitor Y-27632 promotes activation of AKT [31] . Apart from the changes in cytoskeleton, there are several mechanisms by which the ROCK inhibitors RKI-1447 and Fasudil could facilitate differentiation in ESCs of mouse and human origin. The two widely described mechanisms are the effects of ROCK inhibition on b-catenin translocation and TGF-b pathway activity. A discovery in zebrafish embryos revealed that ROCK2 inhibits mesoderm formation through the control of the TGFb pathway [32] . Inhibition of ROCK in embryonal carcinoma stem cells has shown to induce mesoderm and neuroectodermal lineages by blocking endoderm lineage formation [26] . However, in both the studies the concentration of the ROCK inhibitors used is more than 10 mM. At higher concentrations of ROCK inhibitors we have also seen the formation of mesoderm (data not shown). This can be due to the lack of subcellular translocation of b-catenin from the cell junctions to the nucleus, thereby blocking endoderm formation [26] . In regards to the results of this study, it would be interesting to know if high levels of ROCK inhibition have similar influences on the TGFb pathway in hESCs and whether the used ROCK inhibitors, especially RKI-1447 would influence this regulation. Furthermore, we tested the differentiation potential of the chemicallyinduced endoderm towards pancreatic progenitor cells [5] . Fasudil and RKI-1447-induced ADE efficiently generated PDX1 þ pancreatic progenitors. When compared to the standard WNT3A/AA conditions, the efficiency of Fasudil and RKI-1447-induced PDX1 þ cells was similar.
Previous data have suggested that Rho-ROCK signaling regulates Hippo signaling pathway that, in turn, plays pivotal roles in cell lineage specification of the mouse blastocyst [33] . The major components of Hippo signaling, YAP-TEAD proteins, are also known to regulate pancreatic lineages during development [34] . A study on the enhancer network of human embryonic pancreatic progenitors recently has shown the presence of YAP in the nucleus of the hESCs. Upon differentiation of exocrine and endocrine pancreatic lineages, the nuclear localization of YAP is abolished, suggesting the activation of Hippo pathway in these cells [34] . Therefore, it is tempting to assume that the alteration of the actin cytoskeleton due to the administration of ROCK inhibitors might induce the Hippo pathway driving the differentiation of ADE cells towards the pancreatic lineage. Thus, differentiation using ROCK inhibitors can play an important role in early lineage formation and specification of stem cells towards the DE and pancreatic lineage. The addition of single small molecules to current differentiation protocols can further simplify the existing ones and make them more robust for future GMP-production of cell products.
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